| Literature DB >> 27660486 |
Anna Marcuzzi1, Catherine M Dean1, Paul J Wrigley2, Rosemary J Chakiath2, Julia M Hush1.
Abstract
Quantitative sensory testing (QST) measures have recently been shown to predict outcomes in various musculoskeletal and pain conditions. The aim of this systematic review was to summarize the emerging body of evidence investigating the prognostic value of QST measures in people with low back pain (LBP). The protocol for this review was prospectively registered on the International Prospective Register of Systematic Reviews. An electronic search of six databases was conducted from inception to October 2015. Experts in the field were contacted to retrieve additional unpublished data. Studies were included if they were prospective longitudinal in design, assessed at least one QST measure in people with LBP, assessed LBP status at follow-up, and reported the association of QST data with LBP status at follow-up. Statistical pooling of results was not possible due to heterogeneity between studies. Of 6,408 references screened after duplicates removed, three studies were finally included. None of them reported a significant association between the QST measures assessed and the LBP outcome. Three areas at high risk of bias were identified which potentially compromise the validity of these results. Due to the paucity of available studies and the methodological shortcomings identified, it remains unknown whether QST measures are predictive of outcome in LBP.Entities:
Keywords: cohort studies; low back pain; pain; prognosis; quantitative sensory testing; sensory testing
Year: 2016 PMID: 27660486 PMCID: PMC5019427 DOI: 10.2147/JPR.S115659
Source DB: PubMed Journal: J Pain Res ISSN: 1178-7090 Impact factor: 3.133
Figure 1Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart.
Abbreviations: LBP, low back pain; QST, quantitative sensory testing.
Characteristics of samples in the included studies
| Characteristics | LeResche et al | Mlekusch et al | Nordeman et al |
|---|---|---|---|
| Geographical area | USA (Seattle) | Switzerland | Sweden |
| Setting | Primary care | Tertiary care | Primary care |
| Population under study | Acute LBP | Chronic LBP | Chronic LBP |
| Exclusion criteria for LBP | LBP due to neoplastic, infectious or inflammatory cause, pregnancy or major trauma | LBP with radicular pain confirmed by MRI finding of nerve compression together with symptoms or signs of nerve dysfunction | LBP due to pregnancy, known spinal disorders, or other severe disorders |
| Female, n (%) | 157 | 113 (57) | 130 (100) |
| Mean age (SD), years | 47.4 (12.4) | 50.8 (15.4) | 45 (10) |
| Mean pain duration (SD), years | LBP ≤30 days (in 65% of sample) | 6.1 (6.4) | 9.6 (8.8) |
| Follow-up duration | 4 months | 12 to 15 months | 2 years |
| Loss to follow-up (%) | 6 | 0 | 5 |
| Events, n (%) | 44 (30) | N/A | 27 (22) |
Notes:
The cohort was 571, but only 157 participated in the QST;
for LeResche et al,29 this is the number of people who had clinically significant pain at 4 months; for Nordeman et al,30 this is the number of people who were in the “no work ability” category at 2 years.
Abbreviations: LBP, low back pain; SD, standard deviation; N/A, not applicable; MRI, magnetic resonance imaging; QST, quantitative sensory testing.
Risk of bias assessment using the adapted version of the QUIPS tool
| Reference | Sampling
| Study attrition | Prognostic factors measurement | Outcome measurement | Study confounding | Statistical analysis and reporting | |
|---|---|---|---|---|---|---|---|
| Sample defined | Sample representative | ||||||
| LeResche et al | Yes | Unclear | Yes | Unclear | Yes | Yes | Yes |
| Mlekusch et al | Yes | No | Yes | Yes | Yes | Yes | Yes |
| Nordeman et al | Yes | Unclear | Yes | Unclear | Unclear | Yes | Yes |
Abbreviation: QUIPS, Quality in Prognostic Studies.
Summary of the main findings
| Reference | Stimulus | Pain measure | Site | Other variables | Outcome measure | Statistical analysis | Results (univariate analyses) | Conclusions |
|---|---|---|---|---|---|---|---|---|
| LeResche et al | Pressure | Pain threshold | Back and hand | Age | Clinical significant pain measured by the Graded Chronic Pain Scale: “no” defined as grade 0 or 1; “yes” defined as grade II, III, IV | Univariate and multivariable logistic regression | Only PPT at the back and PPT at the thenar eminence were significantly associated with clinically significant pain at 4 months ( | None of the QST measures were significant predictors of clinical significant pain at 4 months after controlling for patient age and sex |
| Mlekusch et al | Pressure | Pain tolerance | Toe | Pain severity and duration, age, sex, catastrophizing, depression, intake of opioids | Change score in average pain intensity over the last 24 hours measured by numeric rating scale (NRS11) | Univariate and multivariable linear regression | None of the QST variables showed an association with change score in pain severity at 1 year | None of the QST measures were significantly associated with change score in pain severity at 1 year in both the unadjusted and adjusted analyses |
| Nordeman et al | Pressure | Pain threshold | Trapezius, supraspinatus, gluteal, and knee bilaterally | Age, baseline work ability, walking test, hand grip strength, number of pain localizations, widespread pain, pain severity, fatigue, activity limitation, social support, risk of long-term disability, stress, anxiety, depression, general health status | work ability: “no” defined as full-time sick leave or full-time disability pension | Univariate and forward stepwise logistic regression | PPT was significantly associated with work ability at 2 years ( | walking ability together with depression score and baseline work ability were significant predictors accounting for 51% of the variance in work ability at 2 years |
Abbreviations: PPT, pressure pain threshold; CPM, conditioned pain modulation; PPtol, pressure pain tolerance; CS, conditioning stimulus; TS, test stimulus; QST, quantitative sensory testing.
Ovid Medline search
| 1. exp cohort studies/ |
| 2. incidence/ |
| 3. follow up stud*.mp. |
| 4. prognos*.mp. |
| 5. predict*.mp. |
| 6. course.mp. |
| 7. inception.mp. |
| 8. exp survival analysis/ |
| 9. exp risk/ |
| 10. observational study/ |
| 11. longitudinal studies/ |
| 12. or/1–11 |
| 13. back pain/ |
| 14. low back pain/ |
| 15. back disorder*.mp. |
| 16. (lumbar adj pain).ti,ab. |
| 17. sciatica/ |
| 18. sciatic neuropathy/ |
| 19. intervertebral Disc Degeneration/ |
| 20. (dis* adj1 prolapse*).ti,ab. |
| 21. (dis* adj1 herniat*).ti,ab. |
| 22. (facet adj joint*).ti,ab. |
| 23. backache.ti,ab. |
| 24. dorsalgia.mp. |
| 25. or/13–24 |
| 26. exp Pain Perception/ |
| 27. pain, referred/ |
| 28. allodynia.ti,ab. |
| 29. neuralgia/ |
| 30. hypersensit*.mp. |
| 31. hyperpathia.ti,ab. |
| 32. exp somatosensory disorders/ |
| 33. sensory profile*.mp. |
| 34. hyp?algesia.ti,ab. |
| 35. hyperalg?esia.ti,ab. |
| 36. paresth?esia.ti,ab. |
| 37. hyperesth?esia.ti,ab. |
| 38. dysesth?esia.ti,ab. |
| 39. hyp?esthesia.ti,ab. |
| 40. peripheral sensit*.ti,ab. |
| 41. central sensit*.ti,ab. |
| 42. spinal sensit*.ti,ab. |
| 43. central pain.ti,ab. |
| 44. (quantitative sensory test* or QST).mp. |
| 45. experim* pain.mp. |
| 46. ((pain adj test*) or (pain adj measure*)).mp. |
| 47. bedside exam*.mp. |
| 48. psychophysic*.mp. |
| 49. electrophysiologic*.mp. |
| 50. (temporal summation or windup or wind up).mp. |
| 51. (second* adj pain).ti,ab. |
| 52. (two-point discrimination or TPD).mp. |
| 53. tactile acuity.ti,ab. |
| 54. (cold pressor test or CPT).mp. |
| 55. (diffuse noxious inhibitory control or DNiC).mp. |
| 56. (pain modul* or descending modul*).mp. |
| 57. (conditioned pain modulation or CPM).mp. |
| 58. offset analgesia.mp. |
| 59. neural inhibition/ |
| 60. (nociceptive withdrawal reflex or NWR or nociceptive flexion reflex or NFR).mp. |
| 61. (reflex receptive field or RRF).mp. |
| 62. (spinal reflex* or (RIII adj reflex)).mp. |
| 63. pain threshold/ |
| 64. Nociceptors/ |
| 65. ((pressure or thermal or cold or heat or eletrical or mechanical) adj pain).ti,ab. [mp=title, abstract, original title, name of substance word, subject heading word, keyword heading word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier] |
| 66. ((cold or warm) adj detection).ti,ab. |
| 67. ((pain adj2 tolerance) or (pain adj2 processing) or detection threshold).ti,ab. |
| 68. or/26–67 |
| 69. 12 and 25 and 68 |
| 70. 69 not randomized controlled trial/ |